Feedback
Below are some examples of feedback we have received from users of Evolve Plus:-
i. Psoriasis sufferer [1]
has long term psoriasis
says Evolve Plus is the best emollient has used over the past 15-years
finds Evolve Plus effectively stops the itch associated with his psoriasis
and that the emollient effects of Evolve Plus last all day from a single application
ii. Psoriasis sufferer [2]
has stable (long term) plaque psoriasis
has been applying traditional emollients and steroid cream (Dovobet) in repeated 3-week and 2-week cycles respectively for some
time
finds Evolve Plus superior to any other emollient he has been prescribed over the past 10-years (including Diprobase and E45 Cream etc)
finds Evolve Plus greatly enhances the action of Dovobet more than any other emollient he has used
iii. Female eczema sufferer
Likes using Evolve Plus because after application (unlike other emollients) she “doesn’t feel like a cross channel swimmer wearing an inch of lard.”
iv. Consultant Dermatologist [1]
It is “nice to know people are applying some science to emollient therapy”
v. Consultant Dermatologist [2]
within a matter of days of Evolve Plus being launched we were informed that Evolve Plus should be on the drug tariff
vi. Mother of a child suffering from scleroderma
“My daughter has scleroderma and has found Evolve Plus useful.
Please would you let me know when it will be available on prescription?”
vii. Mother of child suffering from eczema
My daughter is happy to use Evolve Plus.
“It absorbs into the skin effortlessly unlike gloopy, thick creams.”
viii. General Practitioner
“The spray goes on easily and is quite substantive – it doesn’t disappear too soon.”
Evolve Plus “causes no irritation.”
ix. Paediatric Dermatology Nurse
Evolve Plus “is very nice”
“Patients who have had the samples have liked it - they would use it if it were on prescription.”
“Some have asked where they can but it – is it available in pharmacies?”
“I’ve tried it too as I get mild eczema on my leg and do a lot of swimming so it’s been great”

